Literature DB >> 8989431

The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque.

C D Pauza1, P W Hinds, C Yin, T S McKechnie, S B Hinds, M S Salvato.   

Abstract

Pertussis toxin from the gram-negative bacterium Bordetella pertussis is an ADP-ribosylase that modifies Gi proteins in mammalian lymphocytes and inhibits their capacity to traffic from blood into lymphoid tissues. We used this compound to induce lymphocytosis in rhesus macaques and to study its effects on SIV infection. Pertussis toxin injected at 25 micrograms/kg induced a transient lymphocytosis that peaked 3-8 days after administration and caused a rapid, transient decrease in the frequency of infectious cells in blood as judged by in vitro virus isolation assays. Lymphocyte subsets were altered during the lymphocytosis interval and sustained changes in CD8+ T cell levels were noted as long as 53 days after pertussis toxin injection. In situ hybridization studies showed that pertussis toxin altered the distribution of viral RNA in lymph nodes during the interval of lymphocytosis, and caused long-term changes with decreased virus replication in some tissue specimens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989431      PMCID: PMC3965356          DOI: 10.1089/aid.1997.13.87

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  27 in total

1.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

2.  Pertussis toxin induces lymphocytosis in rhesus macaques.

Authors:  P W Hinds; C Yin; M S Salvato; C D Pauza
Journal:  J Med Primatol       Date:  1996-12       Impact factor: 0.667

Review 3.  New concepts in the immunopathogenesis of HIV infection.

Authors:  G Pantaleo; A S Fauci
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

4.  Stages in LAV/HTLV-III lymphadenitis. I. Histological and immunohistological classification.

Authors:  G Pallesen; J Gerstoft; L Mathiesen
Journal:  Scand J Immunol       Date:  1987-01       Impact factor: 3.487

5.  Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus.

Authors:  A A Lackner; P Vogel; R A Ramos; J D Kluge; M Marthas
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

6.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

Authors:  D D Ho; A U Neumann; A S Perelson; W Chen; J M Leonard; M Markowitz
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

Review 7.  Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection.

Authors:  G Pantaleo; C Graziosi; J F Demarest; O J Cohen; M Vaccarezza; K Gantt; C Muro-Cacho; A S Fauci
Journal:  Immunol Rev       Date:  1994-08       Impact factor: 12.988

8.  Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.

Authors:  S Honda; J J Campbell; D P Andrew; B Engelhardt; B A Butcher; R A Warnock; R D Ye; E C Butcher
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

9.  Studies on the leukocytosis and lymphocytosis induced by Bordetella pertussis. 3. The distribution of transfused lymphocytes in pertussis-treated and normal mice.

Authors:  S I Morse; B A Barron
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules.

Authors:  R F Bargatze; E C Butcher
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  11 in total

1.  Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin.

Authors:  R Latif; N Kerlero de Rosbo; T Amarant; R Rappuoli; G Sappler; A Ben-Nun
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 2.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

3.  Preliminary studies on the use of pertussis toxin for the modulation of intravaginal SIV transmission in rhesus macaques.

Authors:  Kristina Ortiz; Rebecca S Sampathkumar; Aftab A Ansari; Siddappa N Byrareddy
Journal:  J Med Primatol       Date:  2017-09-21       Impact factor: 0.667

4.  Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.

Authors:  Igor S Lukashevich; Mahmoud Djavani; Juan D Rodas; Juan C Zapata; Amy Usborne; Carol Emerson; Jacque Mitchen; Peter B Jahrling; Maria S Salvato
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

5.  CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.

Authors:  K K Steger; M Dykhuizen; J L Mitchen; P W Hinds; B L Preuninger; M Wallace; J Thomson; D C Montefiori; Y Lu; C D Pauza
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Asymptomatic simian immunodeficiency virus infection decreases blood CD4(+) T cells by accumulating recirculating lymphocytes in the lymphoid tissues.

Authors:  A R Schenkel; H Uno; C D Pauza
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Dissemination of lymphocytic choriomeningitis virus from the gastric mucosa requires G protein-coupled signaling.

Authors:  C Yin; M Djavani; A R Schenkel; D S Schmidt; C D Pauza; M S Salvato
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.

Authors:  Juan D Rodas; Igor S Lukashevich; Juan C Zapata; Cristiana Cairo; Ilia Tikhonov; Mahmoud Djavani; C David Pauza; Maria S Salvato
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

9.  The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.

Authors:  M Alfano; H Schmidtmayerova; C A Amella; T Pushkarsky; M Bukrinsky
Journal:  J Exp Med       Date:  1999-09-06       Impact factor: 14.307

Review 10.  Association of Pertussis Toxin with Severe Pertussis Disease.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Toxins (Basel)       Date:  2019-06-27       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.